Trial to Assess the Safety and Effectiveness of the SYNERGYTM Stent System for the Treatment of Atherosclerotic Lesion(s)

What we are studying

The purpose of this research study is to compare the safety and effectiveness of two drug-eluting stents in the treatment of coronary artery disease: the SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY stent) and the PROMUS Element™ Plus Everolimus Eluting Platinum Chromium Coronary Stent System (PROMUS Element Plus stent).

Who we are studying

Men and Women
Races:
- White
- African American
- Asian
- American Indian or Alaska Native
- Native Hawaiian or Pacific Islander
- Other
All Ethnicities
Ages 18+

Eligibility Criteria

At least 18 years of age
Eligible for percutaneous coronary intervention (PCI)
Symptomatic coronary artery disease
Candidate for coronary artery bypass grafting (CABG)

What is involved

Random assignment to treatment group
Screening visits and tests
Placement of coronary stent
Medication therapy after surgery
3 in person follow-up visits
5 phone follow-up visits

Compensation:

No payment will be made to you for your participation in this study. However reasonable travel expenses up to $50, outside your hospital visits that are part of your routine care, will be paid when visits are completed in the office.